USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/8778
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarea, Dumitru
dc.contributor.authorVîrtosu, Ana
dc.contributor.authorAlexa, Zinaida
dc.contributor.authorAnestiadi, Zinaida
dc.date.accessioned2020-04-25T14:41:55Z
dc.date.available2020-04-25T14:41:55Z
dc.date.issued2012
dc.identifier.citationHAREA, D., VÎRTOSU, A., ALEXA, Z., ANESTIADI, Z. Hipertiroidia subclinică – între teorie şi aplicaţie practică. In: Curierul Medical. 2012, nr. 3(327), pp. 212-214. ISSN 1875-0666en_US
dc.identifier.issn1875-0666
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2016/09/18.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/8778
dc.descriptionDepartment of Endocrinology, Republican Clinical Hospital, Congresul III al Medicilor de Familie din Republica Moldova, 17–18 mai, 2012, Chişinău, Republica Moldova, Conferinţa Naţională „Maladii bronhoobstructive la copii”, consacrată profesorului universitar, doctor habilitat Victor Gheţeul, 27 aprilie, Chişinău, Republica Moldovaen_US
dc.description.abstractSubclinical hyperthyroidism is defined as persistently low or undetectable serum TSH and normal thyroid hormones (FT4, FT3). The need to keep updated information about subclinical hyperthyroidism is conditioned by the increase of the incidence of this disease. This nosologic condition needs to be analyzed in the long term regarding its implications and risks (especially cardiovascular), subclinical thyroid dysfunction having often an asymptomatic evolution. The necessity of a therapeutic approach to subclinical hyperthyroidism represents a difficult aspect of hyperthyroidism.en_US
dc.description.abstractСубклинический гипертиреоз определяется как устойчиво низкий или неопределяемый уровeнь тиреотропного гормона при нормальных уровнях свободных фракций Т4 и Т3. Увеличение частоты этого заболевания обусловливает необходимость обновления информации о субклиническом гипертиреозе. Это заболевание должно быть проанализировано с точки зрения долгосрочных последствий и рисков (особенно сердечно-сосудистой системы). Cубклиническиe дисфункции щитовидной железы часто протекают бессимптомно. Трудным аспектом является необходимость лечения субклинического гипертиреоза.
dc.language.isoroen_US
dc.publisherMinisterul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”en_US
dc.relation.ispartofCurierul Medical: Congresul III al Medicilor de Familie din Republica Moldova, 17–18 mai, 2012, Chişinău, Republica Moldova, Conferinţa Naţională „Maladii bronhoobstructive la copii”, consacrată profesorului universitar, doctor habilitat Victor Gheţeul, 27 aprilie, Chişinău, Republica Moldova
dc.subjectsinus node dysfunctionen_US
dc.subjectdiagnosisen_US
dc.subjecttreatmenten_US
dc.titleHipertiroidia subclinică – între teorie şi aplicaţie practicăen_US
dc.title.alternativeSubclinical hyperthyroidism – between theory and practiceen_US
dc.title.alternativeСубклинический гипертиреоз – между теорией и практикойen_US
dc.typeArticleen_US
Appears in Collections:Curierul Medical, 2012, Vol. 327, Nr. 3

Files in This Item:
File Description SizeFormat 
Hipertiroidia_subclinica_intre_teorie_si_aplicatie_practica.pdf159.98 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback